These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23470481)

  • 1. [Pharmacological review for drug approval].
    Nishioka K
    Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):155-9. PubMed ID: 23470481
    [No Abstract]   [Full Text] [Related]  

  • 2. From Pharmacology Research, to Pharmacology Regulation, and Back-as Inspired by the Teachings of Dr. Gavril Pasternak.
    Luke MC
    Cell Mol Neurobiol; 2021 Jul; 41(5):835-837. PubMed ID: 32323151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic data submissions to the FDA: clinical pharmacology case studies.
    Ruaño G; Collins JM; Dorner AJ; Wang SJ; Guerciolini R; Huang SM
    Pharmacogenomics; 2004 Jul; 5(5):513-7. PubMed ID: 15212588
    [No Abstract]   [Full Text] [Related]  

  • 4. Biosimilars / Follow-on proteins - a case for clinical pharmacology.
    Sörgel F
    Int J Clin Pharmacol Ther; 2009 Jun; 47(6):365. PubMed ID: 19473597
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution of pharmacology for new drug application in Japan].
    Suzuki-Nishimura T; Toyoshima S; Uyama Y; Yamada H; Hosoki R; Fujimori K; Nagao T
    Nihon Yakurigaku Zasshi; 2002 Sep; 120(3):187-94. PubMed ID: 12271514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease models.
    Gobburu J
    Clin Adv Hematol Oncol; 2008 Apr; 6(4):241-2. PubMed ID: 18496490
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacology and the catalysis of regulatory science: opportunities for the advancement of drug development and evaluation.
    Zineh I; Woodcock J
    Clin Pharmacol Ther; 2013 Jun; 93(6):515-25. PubMed ID: 23571772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two decades of new drug development for central nervous system disorders.
    Kesselheim AS; Hwang TJ; Franklin JM
    Nat Rev Drug Discov; 2015 Dec; 14(12):815-6. PubMed ID: 26585536
    [No Abstract]   [Full Text] [Related]  

  • 9. U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations.
    Zuabi N; Patel B; Langdorf MI
    West J Emerg Med; 2016 Nov; 17(6):741-746. PubMed ID: 27833682
    [No Abstract]   [Full Text] [Related]  

  • 10. Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.
    Ichimaru K; Toyoshima S; Uyama Y
    Clin Pharmacol Ther; 2010 Mar; 87(3):362-6. PubMed ID: 20107436
    [No Abstract]   [Full Text] [Related]  

  • 11. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2008; 21(1):36-43. PubMed ID: 18301808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo pharmacology in drug discovery and development.
    Svendsen O; Ahnfelt-Rønne I; Vanhoutte P
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):89-90. PubMed ID: 16918707
    [No Abstract]   [Full Text] [Related]  

  • 13. Globalization of quantitative pharmacology: first international symposium of quantitative pharmacology in drug development and regulation.
    Barrett JS; Shi J; Xie HT; Huang XH; Fossler MJ; Sun RY
    J Clin Pharmacol; 2008 Jul; 48(7):787-92. PubMed ID: 18490494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Has the food and drug administration changed the drug approval process?
    Somberg JC
    Am J Ther; 2011 May; 18(3):179. PubMed ID: 21566467
    [No Abstract]   [Full Text] [Related]  

  • 15. Generic drug approval: a US perspective.
    Nagori BP; Mathur V; Garg S
    Curr Med Res Opin; 2011 Mar; 27(3):541-5. PubMed ID: 21219120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report calls for major changes in drug-approval process, but will they be implemented?
    Robinson A
    CMAJ; 1993 Feb; 148(3):432-5. PubMed ID: 8439917
    [No Abstract]   [Full Text] [Related]  

  • 17. Accelerated approval: where are we now?
    Delaney M
    Res Initiat Treat Action; 2002; 8(1):18-22. PubMed ID: 12489522
    [No Abstract]   [Full Text] [Related]  

  • 18. Balancing Accelerated Approval for Drugs With Accelerated Withdrawal.
    Braillon A; Menkes DB
    JAMA Intern Med; 2016 Apr; 176(4):566-7. PubMed ID: 27043114
    [No Abstract]   [Full Text] [Related]  

  • 19. American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation.
    Morrow JD; Edeki TI; El Mouelhi M; Galinsky RE; Kovelesky R; Noveck RJ; Preuss C;
    Clin Pharmacol Ther; 2005 Mar; 77(3):113-22. PubMed ID: 15735605
    [No Abstract]   [Full Text] [Related]  

  • 20. Balancing Accelerated Approval for Drugs With Accelerated Withdrawal--Reply.
    Kim C; Prasad V
    JAMA Intern Med; 2016 Apr; 176(4):567. PubMed ID: 27043117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.